Literature DB >> 20949328

Are physicians' recommendations for colorectal cancer screening guideline-consistent?

K Robin Yabroff1, Carrie N Klabunde, Gigi Yuan, Timothy S McNeel, Martin L Brown, Dana Casciotti, Dennis W Buckman, Stephen Taplin.   

Abstract

BACKGROUND: Many older adults in the U.S. do not receive appropriate colorectal cancer (CRC) screening. Although primary care physicians' recommendations to their patients are central to the screening process, little information is available about their recommendations in relation to guidelines for the menu of CRC screening modalities, including fecal occult blood testing (FOBT), flexible sigmoidoscopy (FS), colonoscopy, and double contrast barium enema (DCBE). The objective of this study was to explore potentially modifiable physician and practice factors associated with guideline-consistent recommendations for the menu of CRC screening modalities.
METHODS: We examined data from a nationally representative sample of 1266 physicians in the U.S. surveyed in 2007. The survey included questions about physician and practice characteristics, perceptions about screening, and recommendations for age of initiation and screening interval for FOBT, FS, colonoscopy and DCBE in average risk adults. Physicians' screening recommendations were classified as guideline consistent for all, some, or none of the CRC screening modalities recommended. Analyses used descriptive statistics and polytomous logit regression models.
RESULTS: Few (19.1%; 95% CI:16.9%, 21.5%) physicians made guideline-consistent recommendations across all CRC screening modalities that they recommended. In multivariate analysis, younger physician age, board certification, north central geographic region, single specialty or multi-specialty practice type, fewer patients per week, higher number of recommended modalities, use of electronic medical records, greater influence of patient preferences for screening, and published clinical evidence were associated with guideline-consistent screening recommendations (p < 0.05).
CONCLUSIONS: Physicians' CRC screening recommendations reflect both overuse and underuse, and few made guideline-consistent CRC screening recommendations across all modalities they recommended. Interventions that focus on potentially modifiable physician and practice factors that influence overuse and underuse and address the menu of recommended screening modalities will be important for improving screening practice.

Entities:  

Mesh:

Year:  2010        PMID: 20949328      PMCID: PMC3019313          DOI: 10.1007/s11606-010-1516-5

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  38 in total

1.  The effects of physician supply on the early detection of colorectal cancer.

Authors:  R G Roetzheim; N Pal; E C Gonzalez; J M Ferrante; D J Van Durme; J Z Ayanian; J P Krischer
Journal:  J Fam Pract       Date:  1999-11       Impact factor: 0.493

2.  Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.

Authors:  P C Schroy; A C Geller; M Crosier Wood; M Page; L Sutherland; L J Holm; T Heeren
Journal:  Prev Med       Date:  2001-11       Impact factor: 4.018

3.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

4.  Healthcare system factors and colorectal cancer screening.

Authors:  Jane G Zapka; Elaine Puleo; Maureen Vickers-Lahti; Roger Luckmann
Journal:  Am J Prev Med       Date:  2002-07       Impact factor: 5.043

5.  A national survey of primary care physicians' colorectal cancer screening recommendations and practices.

Authors:  Carrie N Klabunde; Paul S Frame; Ann Meadow; Elizabeth Jones; Marion Nadel; Sally W Vernon
Journal:  Prev Med       Date:  2003-03       Impact factor: 4.018

6.  Colorectal cancer screening by primary care physicians in two medical care organizations.

Authors:  S T Hawley; B Levin; S W Vernon
Journal:  Cancer Detect Prev       Date:  2001

7.  Explaining physician rates of providing flexible sigmoidoscopy.

Authors:  D E Montaño; W R Phillips; D Kasprzyk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-07       Impact factor: 4.254

8.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence.

Authors:  Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

Review 9.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

10.  Adverse events after outpatient colonoscopy in the Medicare population.

Authors:  Joan L Warren; Carrie N Klabunde; Angela B Mariotto; Angela Meekins; Marie Topor; Martin L Brown; David F Ransohoff
Journal:  Ann Intern Med       Date:  2009-06-16       Impact factor: 25.391

View more
  38 in total

1.  Predictors of Poor Adherence of US Gastroenterologists with Colonoscopy Screening and Surveillance Guidelines.

Authors:  Heba Iskandar; Yan Yan; Jill Elwing; Dayna Early; Graham A Colditz; Jean S Wang
Journal:  Dig Dis Sci       Date:  2014-11-04       Impact factor: 3.199

2.  Evaluating a De-Centralized Regional Delivery System for Breast Cancer Screening and Patient Navigation for the Rural Underserved.

Authors:  Stephen J Inrig; Jasmin A Tiro; Trisha V Melhado; Keith E Argenbright; Simon J Craddock Lee
Journal:  Tex Public Health J       Date:  2014

3.  Overuse of colonoscopy for colorectal cancer screening and surveillance.

Authors:  Gina R Kruse; Sami M Khan; Alan M Zaslavsky; John Z Ayanian; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2014-09-30       Impact factor: 5.128

4.  Going against medical advice: PCPs' role in reducing colonoscopy overuse.

Authors:  Archana Radhakrishnan; Craig Evan Pollack
Journal:  J Gen Intern Med       Date:  2015-03       Impact factor: 5.128

5.  Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems.

Authors:  Nirupa R Ghai; Christopher D Jensen; Sophie A Merchant; Joanne E Schottinger; Jeffrey K Lee; Jessica Chubak; Aruna Kamineni; Ethan A Halm; Celette Sugg Skinner; Jennifer S Haas; Beverly B Green; Nancy T Cannizzaro; Jennifer L Schneider; Douglas A Corley
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-15

Review 6.  Colorectal cancer screening--optimizing current strategies and new directions.

Authors:  Ernst J Kuipers; Thomas Rösch; Michael Bretthauer
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

7.  Family Physicians' Knowledge, Attitudes, and Practices Toward Colorectal Cancer Screening.

Authors:  Mustafa Kürşat Şahin; Servet Aker
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

8.  One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines.

Authors:  María Elena Martínez; Patricia Thompson; Karen Messer; Erin L Ashbeck; David A Lieberman; John A Baron; Dennis J Ahnen; Douglas J Robertson; Elizabeth T Jacobs; E Robert Greenberg; Amanda J Cross; Wendy Atkin
Journal:  Ann Intern Med       Date:  2012-12-18       Impact factor: 25.391

9.  Underuse and Overuse of Colonoscopy for Repeat Screening and Surveillance in the Veterans Health Administration.

Authors:  Caitlin C Murphy; Robert S Sandler; Janet M Grubber; Marcus R Johnson; Deborah A Fisher
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-19       Impact factor: 11.382

10.  Risk of colorectal adenomas in women with prior breast cancer.

Authors:  Ashish Shukla; Sandhya Shukla; Ayodele Osowo; Terry Mashtare; Manoop S Bhutani; Sushovan Guha
Journal:  Dig Dis Sci       Date:  2012-10-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.